Loading...

Bonus BioGroup Ltd.

BBIXF•PNK
Healthcare
Biotechnology
$0.13
$0.00(0.00%)
U.S. Market opens in 10h 13m

Bonus BioGroup Ltd. (BBIXF) Stock Overview

Explore Bonus BioGroup Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap151.8M
P/E Ratio-14.64
EPS (TTM)$-0.01
ROE-15.41%
Fundamental Analysis

AI Price Forecasts

1 Month$0.12
3 Months$0.10
1 Year Target$0.08

BBIXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bonus BioGroup Ltd. (BBIXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 78.17, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.64 and a market capitalization of 151.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
30.00%
1-Month Change
8.33%
3-Month Change
30.00%
6-Month Change
43233.33%
Year-to-Date (YTD) Change
62.50%
1-Year Change
333.33%
3-Year Change
550.00%
5-Year Change
30.00%
All-Time (Max) Change
1.09%

Contact Information

https://www.bonusbiogroup.com
972 7 320 67104
Matam Advanced Technology Park, Haifa, NaN, 31905

Company Facts

49 Employees
IPO DateJul 30, 2019
CountryIL
Actively Trading

Frequently Asked Questions